Top Suppliers:I want be here

101831-36-1

101831-36-1 structure
101831-36-1 structure
  • Name: Clazuril
  • Chemical Name: 2-[2-chloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]-2-(4-chlorophenyl)acetonitrile
  • CAS Number: 101831-36-1
  • Molecular Formula: C17H10Cl2N4O2
  • Molecular Weight: 373.19300
  • Catalog: analytical chemistry Standard Pharmacopoeia Standards and Magazine Standards
  • Create Date: 2018-07-02 17:51:37
  • Modify Date: 2024-01-10 19:35:32
  • Clazuril (R62690) has a coccidiocidal effect on the asexual and sexual developmental stages of both Eimeria species, resulting in a complete interruption of the life cycle[1].

Name 2-[2-chloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]-2-(4-chlorophenyl)acetonitrile
Synonyms CLAZURIL
Clazurilum [Latin]
[2-chloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3h)-yl)phenyl](4-chlorophenyl)acetonitrile
Clazurilo [Spanish]
Clazuril (USAN/INN)
Clazurilo
Clazurilum
Description Clazuril (R62690) has a coccidiocidal effect on the asexual and sexual developmental stages of both Eimeria species, resulting in a complete interruption of the life cycle[1].
Related Catalog
In Vivo Clazuril (2.5 mg/pigeon) results in a rapid suppression of oocyst excretion, but oocysts are again observed in the feces 20 days after treatment. The fact that oocysts appears again in the feces 3 to 5 weeks after treatment can probably be explained only by a persistence of endogenous stages, which are not affected during treatment, rather than by a reinfection [2].
References

[1]. W Coussement, et al. Action of the anticoccidial clazuril on the endogenous stages of Eimeria labbeana and E columbarum in experimentally infected pigeons. Res Vet Sci. 1988 Jul;45(1):117-9.

[2]. J Vercruysse, et al. Efficacy of toltrazuril and clazuril against experimental infections with Eimeria labbeana and E. columbarum in racing pigeons. Avian Dis. Jan-Mar 1990;34(1):73-9.

Density 1.48g/cm3
Melting Point 196.8°
Molecular Formula C17H10Cl2N4O2
Molecular Weight 373.19300
Exact Mass 372.01800
PSA 91.54000
LogP 2.88308
Index of Refraction 1.692

~11%

101831-36-1 structure

101831-36-1

Literature: Janssen Pharmaceutica N.V. Patent: US4631278 A1, 1986 ;